"Short Name","Full Name",Year,Term,Faculty,"Course Types",Credits,Instructors,TAs,"Assessment count","Session count","Course outcome","Tagged program objectives"
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Identify health, medication management and safety needs for patients.","1.8.5 determine changes in pharmacotherapy that are required.","3.1.1 Exposure -  Explores own professional ethical considerations, role and scope of practice in IP contexts ","3.1.3 Integration -  Builds confidence in and maintains scope of practice in IP context "
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Identify aspects of design that impact patient ability to manage medications.","3.2 Interpretive proficiency","3.4 Information literacy"
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Consider disease and functional/disability information as relevant to the specific design needs. ","1.1.2 demonstrate that the patient's goals are the priority;","1.1.3 determine when it is ethically and professionally appropriate to involve caregivers;","1.1.4 acknowledge and respect the roles and responsibilities of the pharmacist, the patient and/or caregivers, and the patient's other health care professionals (9).","1.2 Elicit and complete an assessment of required information to determine the patient's medication related and other relevant health needs.","1.2.1 elicit the reason(s) for the patient's visit to the pharmacy or encounter with the pharmacist;","1.2.2 obtain and evaluate relevant history from the patient, his/her chart, electronic health record, caregivers and other health care professionals;","1.2.3 order, retrieve and assess relevant lab tests, point-of-care tests, and diagnostic assessments;","1.2.4 perform and interpret findings of relevant physical assessments that are required to","1.2.5 complete an assessment of the patient's ability to take / use / administer his/her medications.","1.3 Assess if a patient's medication-related needs are being met.","1.3.1 evaluate the safety and effectiveness of a patient's medications with consideration of the patient's values and preferences, characteristics, conditions, functional capabilities, other medications and access to health care / monitoring;"
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Describe features of universal design."
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Classify forms of disability and identify functional supports associated with those disabilities."
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Explain the current approach to pharmacy visits for individuals with disabilities, as completed by Alberta Committee on Citizens with Disabilities (ACCD)."
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Develop design features that ensure patients’ medication access, safety, health and medication management/monitoring"
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Demonstrate patient/client-centered (individual, family, community group) approach in design.","3.7.1 novice ","2.6.1 novice "
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Develop writing and presentation skills (oral, written) to demonstrate effectively the team’s final design in front of peers, clients, or experts in design and health services.","1.2.3 competent "
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Actively listen and engage in negotiation with clients to effectively plan the approach for the project."
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Professional Roles a.	Share and evaluate own professional values and culture (translates knowledge to team members) b.	Articulate and share knowledge of other professional roles c.	Consult, seeks advice and confer with other professionals d.	Adapt professional role within a given context/ environment","3.5.3 competent ","1.2.3 competent ","1.5.1 novice ","3.1.2 Immersion -  Shares and evaluates own professional values and culture (translates knowledge to team members) ","3.1.5 Immersion -  Articulates and shares knowledge of other professional roles ","3.2.3 Immersion -  Consults, seeks advice and confers with other professionals "
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Communication  a.	Integrate feedback into professional and team practice b.	Match level and mode of communication to the needs of team members c.	Actively listen and be receptive to the knowledge and opinions of others d.	Analyze conflict effectively and employ appropriate conflict resolution techniques/models e.	Develop presentations that consider the audience background, context, and learning needs","1.5.3 competent ","3.5.3 competent ","4.1.11 Immersion -  1C3. Active listening and respect for others opinions and practices are consistently demonstrated","4.1.2 Immersion -  Matches level and mode of communication to the needs of team members (patient, family, health professionals)","4.1.12 Integration -  Integrates feedback into professional and team practice "
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Collaboration a.	Identify and employ appropriate technologies to facilitate collaboration b.	Employ appropriate team role behaviours to support team function c.	Takes action in instances where there is a lack of inclusivity, respect, or trust on the team d.	Identify opportunities to improve team outcomes  e.	Negotiate action with team members to plan and execute team tasks","3.5.3 competent ","3.4.3 competent ","2.4.1 novice ","1.2.3 competent ","1.5.3 competent ","1.1.3 Exposure -  Identifies and employs appropriate technologies to facilitate collaboration ","2.1.2 Immersion -  Employs appropriate team role behaviors to support team function ","1.2.5 Integration -  Takes action in instances where there is a lack of inclusivity, respect, or trust on the team "
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Reflection a.	Takes action based on reflection to improve personal and team performance  b.	Reflect on pharmacists’ contribution to the process. c.	Explore strengths and weaknesses in team composition and process","2.2.25 Immersion -  Takes action based on reflection to improve professional and team performance ","2.2.10 Exposure -  Explores strengths and weaknesses in team composition and process ","2.2.1 Exposure -  Identifies professional requirements for self-reflection"
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Express empathy for those experiencing disabilities, impairments, or handicaps."
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Listen to others with respect."
"PHARM 452 (LEC A1 Fa16)","PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Cheryl Sadowski",,7,14,"Appreciates the role of advocacy for those who are vulnerable."
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","2.4.1 novice "
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"Identify and debate key issues and challenges facing the Canadian healthcare system.","2.4.1 novice "
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.","2.4.1 novice "
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.","2.4.1 novice ","3.1 Understand expertise, roles and responsibilities of IP team members","3.1.10 Exposure -  1B2: Ones own role, nature and scope of practice and the role of others are clearly and concisely described "
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions."
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions."
"PHARM 382 (LEC B1 Wi17)","PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,5,10,"Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system."
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Develop an understanding of the role and expectations of experiential learning in the curriculum "
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Explore the understanding of professionalism as the ability to identify and negotiate the expectations of others","3.1 Understand expertise, roles and responsibilities of IP team members","3.1.4 Exposure -  Explores the professional ethical considerations, roles and scopes of practice of other IP team members ","3.1.1 Exposure -  Explores own professional ethical considerations, role and scope of practice in IP contexts ","3.1.7 Exposure -  Identifies relevant professional roles in a given context, and identify potential gaps in team membership ","3.1.10 Exposure -  1B2: Ones own role, nature and scope of practice and the role of others are clearly and concisely described "
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Demonstrate critical thinking and reflection to optimize learning from experience and care for clients"
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Develop the ability to build collaborative relationships with clients and staff","1.2 Establish and maintain professional relationships with patients and colleagues from ones own and other disciplines"
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident","1.2.2 functional ","2.1.2 functional ","2.2.1 novice "
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges","2.2.8 Immersion -  Analyzes patient centeredness in terms of professional and team practice ","2.2 Evaluate own professional role and team practice","2.2.1 Exposure -  Identifies professional requirements for self-reflection","2.2.9 Integration -  Evaluates and adapts reflective processes in professional practice ","2.2.24 Exposure -  Explores own view of patient centeredness within context to current literature "
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site","1.2.2 functional ","6.3.6 Integration -  3B5: A genuine commitment to patient-centred care is demonstrated","6.3 Contribute to the implementation and monitoring of the care plan"
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Explore how the critical thinking/reflective practice of person-centred care in Pharm 300 relates to the reflective practice of client centered care in pharmacy"
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Demonstrate initiative in service and learning "
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Practice in an ethical manner to assure primary accountability to the client ","3.1.1 Exposure -  Explores own professional ethical considerations, role and scope of practice in IP contexts ","6.3.4 Integration -  Accountability for ones own performance is consistently demonstrated in keeping with all relevant legal, professional, ethical and organizational standards"
"PHARM 300A (LEC C1 Fa16)","PHARM 300A EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Cox, Cheryl",,6,7,"Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional"
"PHARM 316 (Spring 2017 CLN 800 801 802)","PHARM 316 Sp17 - EXPERIENTIAL LEARNING PART 3 Combined CLN Sp17",2017,Spring,"Cross Listed Courses","Experiential,",4,"Thompson, Ann",,0,0,"Provide seamless care by participating in discharge planning/transitions in care (i.e. patient education, discharge med rec, documentation/charting, verbal handover).","3.2.3 competent ","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 316 (Spring 2017 CLN 800 801 802)","PHARM 316 Sp17 - EXPERIENTIAL LEARNING PART 3 Combined CLN Sp17",2017,Spring,"Cross Listed Courses","Experiential,",4,"Thompson, Ann",,0,0,"Participate in site-based advocacy activities (e.g. immunizations, patient education, education strategies regarding appropriate use of medications, disaster planning (i.e. pandemic, floods), how to handle drug shortages)","3.5.3 competent ","SC4.1 Provide effective education to others.","SC4.2 Employ appropriate teaching roles when teaching others.","SC4.3 Deliver effective feedback in teaching and learning situations.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","HA1.2 Work with patients to increase opportunities to adopt healthybehaviours.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them.","HA2.2 Participate in health promotion and disease prevention programs.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare."
"PHARM 316 (Spring 2017 CLN 800 801 802)","PHARM 316 Sp17 - EXPERIENTIAL LEARNING PART 3 Combined CLN Sp17",2017,Spring,"Cross Listed Courses","Experiential,",4,"Thompson, Ann",,0,0,"Use appropriate resources to answer questions posed by patients, the preceptor, team members or the student (i.e. evidence to support patient care decisions); may require preceptor guidance.","3.1.3 competent ","1.1.3 competent "
"PHARM 316 (Spring 2017 CLN 800 801 802)","PHARM 316 Sp17 - EXPERIENTIAL LEARNING PART 3 Combined CLN Sp17",2017,Spring,"Cross Listed Courses","Experiential,",4,"Thompson, Ann",,0,0,"Prepare and deliver a case presentation to pharmacists and/or other healthcare providers.","1.2.3 competent ","3.1.3 competent ","3.5.3 competent ","1.1.3 competent ","6.1 Contribute to the assessment of the patient"
"PHARM 426 (CLN 850 Su16)","PHARM 426 EXPERIENTIAL BLK 2 (Su16)",2017,Summer,"Faculty of Pharmacy and Pharmaceutical Sciences",,8,"Marlene Gukert",,0,0
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Use appropriate resources to answer questions posed by patients, the preceptor, team members or the student (i.e. evidence to support patient care decisions); may require preceptor guidance."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Question and develop knowledge in new areas related to practice and patient care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Engage in continuous professional development through development of learning goals and objectives and the creation of a professional portfolio."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Display patient-centered approach to practice e.g. demonstration of patient accountability.","6.3.4 Integration -  Accountability for ones own performance is consistently demonstrated in keeping with all relevant legal, professional, ethical and organizational standards","6.3.6 Integration -  3B5: A genuine commitment to patient-centred care is demonstrated"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Communicate clearly verbally/non-verbally and in writing with team members and patients.","1.2.3 competent ","4.1.2 Immersion -  Matches level and mode of communication to the needs of team members (patient, family, health professionals)","4.1.6 Integration -  Integrates appropriate verbal and nonverbal communication skills when engaging with others in difficult or high stakes situations "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Perform patient interviews o Systematically gather patient information; including completing Best Possible Medication Histories and medication reconciliation. (This should be completed initially with direct preceptor supervision with progression to independence as appropriate.)"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Assess drug therapies by completing pharmacotherapy workups and care plans with preceptor guidance for a minimum of 3 patients using the elements of the Patient Care Process. o Work through care process (identifying drug related problems, planning care) o Develop decision-making skills required to determine next steps and plan care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Implement care plans with preceptor guidance."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Schedule and complete follow-up (where possible) and evaluate patient outcomes, with preceptor supervision; determine next steps with preceptor."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Document care provided to support continuity of care; review/revise under preceptor guidance."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Educate patients regarding conditions already learned in the curriculum; complete initially with direct preceptor supervision with progression to independence as appropriate."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify and discuss patient-focused pharmacy services that are opportunities to provide patient care. e.g. medication and adherence strategies; flavorings, blister packs, etc."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify and discuss services eligible for reimbursement by Alberta Health and described under the Alberta Pharmacist’s Association Pharmacy Services Framework. http://www.rxa.ca/pharmacy-services-framework/for-the-pharmacist.aspx (Rx adaptation or renewal, emergency prescribing, Comprehensive Annual Care Plans (CACP) and Standard Medication Management Assessments (SMMA), administration of drugs by injection, prescribing at initial access."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Participate in health promotion activities."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Prioritize activities in daily practice to optimize patient care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify and check for required components of prescriptions."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify important components of patient computer profile, and participate in keeping these up-to-date."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Describe and participate in distribution system processes with emphasis on the quality assurance procedures involved."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify efforts required to ensure safe medication distribution and develop an understanding of the importance of each step."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Participate in compounding topical and liquid preparations as opportunities arise."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Discuss application of code of ethics and standards of practice in a community practice setting; including the importance of confidentiality and ethical dilemmas within patient care (e.g. caregiver concerns, elderly living in the community, family tensions.)"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Act and dress professionally; e.g. demonstrate initiative."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Engage respectfully with patients and team members of various special populations and cultures.","1.2.1 Exposure -  Identifies and demonstrates attitudes and behaviours that build a culture of inclusivity, mutual respect and trust ","1.2.2 Exposure -  Diverse professional and cultural values are respected ","4.1.11 Immersion -  1C3. Active listening and respect for others opinions and practices are consistently demonstrated"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Develop professional rapport with patients and other healthcare professionals.","4.1.2 Immersion -  Matches level and mode of communication to the needs of team members (patient, family, health professionals)"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Develop a basic understanding of the importance of inter-professional practice.","1.1.1 Exposure -  Identifies and explores social / professional / organizational opportunities for collaboration "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Collaborate with pharmacy team members and staff as well as patients, and other care professionals to optimize patient care.","2.1 Contribute to the formation and functioning of a collaborative team"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Recognize and respect the roles and responsibilities of pharmacy team members in a community pharmacy practice.","3.1.10 Exposure -  1B2: Ones own role, nature and scope of practice and the role of others are clearly and concisely described "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Develop an understanding of advocacy and leadership roles (e.g. health promotion)"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Promote patient self-care where appropriate."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Use appropriate resources to answer questions posed by patients, the preceptor, team members or the student (i.e. evidence to support patient care decisions); may require preceptor guidance.","1.1.2 functional ","3.1.2 functional ","1.6.3 Integration -  2A6: The necessary resources and administrative support are clearly identified and utilized "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Question and develop knowledge in new areas related to practice and patient care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Engage in continuous professional development through development of learning goals and objectives and the creation of a professional portfolio."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Display patient-centered approach to practice e.g. demonstration of patient accountability."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Communicate clearly verbally/non-verbally and in writing with team members and patients."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Perform patient interviews o Systematically gather patient information; including completing Best Possible Medication Histories and medication reconciliation. (This should be completed initially with direct preceptor supervision with progression to independence as appropriate.)"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Assess drug therapies by completing pharmacotherapy workups and care plans with preceptor guidance for a minimum of 3 patients using the elements of the Patient Care Process. o Work through care process (identifying drug related problems, planning care) o Develop decision-making skills required to determine next steps and plan care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Implement care plans with preceptor guidance.","1.1.1 novice ","3.1.1 novice "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Schedule and complete follow-up (where possible) and evaluate patient outcomes, with preceptor supervision; determine next steps with preceptor."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Document care provided to support continuity of care; review/revise under preceptor guidance."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Educate patients regarding conditions already learned in the curriculum; complete initially with direct preceptor supervision with progression to independence as appropriate."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify and discuss patient-focused pharmacy services that are opportunities to provide patient care. e.g. medication and adherence strategies; flavorings, blister packs, etc."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify and discuss services eligible for reimbursement by Alberta Health and described under the Alberta Pharmacist’s Association Pharmacy Services Framework. http://www.rxa.ca/pharmacy-services-framework/for-the-pharmacist.aspx (Rx adaptation or renewal, emergency prescribing, Comprehensive Annual Care Plans (CACP) and Standard Medication Management Assessments (SMMA), administration of drugs by injection, prescribing at initial access."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Participate in health promotion activities."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Prioritize activities in daily practice to optimize patient care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify and check for required components of prescriptions."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify important components of patient computer profile, and participate in keeping these up-to-date."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Describe and participate in distribution system processes with emphasis on the quality assurance procedures involved."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Identify efforts required to ensure safe medication distribution and develop an understanding of the importance of each step.","3.10.1 novice ","3.7.1 novice "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Participate in compounding topical and liquid preparations as opportunities arise."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Discuss application of code of ethics and standards of practice in a community practice setting; including the importance of confidentiality and ethical dilemmas within patient care (e.g. caregiver concerns, elderly living in the community, family tensions.)","2.1.1 novice ","2.2.1 novice "
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Act and dress professionally; e.g. demonstrate initiative."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Engage respectfully with patients and team members of various special populations and cultures."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Develop professional rapport with patients and other healthcare professionals."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Develop a basic understanding of the importance of inter-professional practice."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Collaborate with pharmacy team members and staff as well as patients, and other care professionals to optimize patient care."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Recognize and respect the roles and responsibilities of pharmacy team members in a community pharmacy practice."
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Develop an understanding of advocacy and leadership roles (e.g. health promotion)"
"PHARM 305 (CLN 850 Su16)","PHARM 305 EXPERIENTIAL LEARNING",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,4,"Marlene Gukert",,0,0,"Promote patient self-care where appropriate."
"PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2)","PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Michael R. Doschak",,3,24,"Describe the Axial and Appendicular skeleton and related joint structures"
"PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2)","PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Michael R. Doschak",,3,24,"Compare and contrast the major rheumatological conditions encountered in clinical practice, with particular emphasis on 5 conditions of major focus (Osteoarthritis, Osteoporosis, Osteomalacia, Rheumatoid Arthritis, Gout & Hyperuricemiua)"
"PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2)","PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Michael R. Doschak",,3,24,"Describe the medicinal chemistry and pharmacology of antiresorptive and anabolic bone drugs, and the disease-modifying anti-rheumatic drugs (DMARDs)"
"PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2)","PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Michael R. Doschak",,3,24,"Show competency in counseling clients/patients on the short- and long-term drug management of rheumatic conditions"
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate use of a therapeutic process to identify and prioritize actual and/or potential drug-related problems using a patient care centered approach."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate self-directed learning abilities and team skills."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15," Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Accept responsibility of keeping current with emerging therapeutic modalities."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate refinement of critical appraisal, written and oral communication skills."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Incorporate principles of evidence-based medicine into therapeutic decision making."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate a confident and competent approach to solving patient concerns."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Apply appropriate documentation skills to facilitate care throughout a variety of settings."
"PHARM 489 (SEM A1 Fa16)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",3,"Sherif Mahmoud",,5,15,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations."
"PHARM 316 (Spring 2016 CLN 800 801 802)","PHARM 316 Sp16 - EXPERIENTIAL LEARNING PART 3 Combined CLN Sp16",2017,Spring,"Cross Listed Courses","Experiential,",4,"Marlene Gukert",,0,0
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Identify the inherent limitations of the drug approval process and pre-­marketing clinical trials with regard to assessment of drug safety and effectiveness."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Define type I and type II errors and power."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"When trying to detect a difference in risk, describe what can influence a study sample size."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe why we need adverse drug reaction reporting systems and how pharmacists can contribute to this process."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Compare type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Define what a safety signal is and how it may be generated."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe the various data sources used in pharmacoepidemiologic studies. Examples will be presented to highlight the advantages and limitations of each data source."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe the major elements of cross-­sectional, case-­control, cohort, and other common designs of pharmacoepidemiologic studies that evaluate drug safety, effectiveness, and utilization patterns."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Interpret different measures of association reported in pharmacoepidemiologic studies (e.g. odds ratio, relative risk, hazard ratio)."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Categorize and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Understand how specific biases may affect measures of association."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Define confounding and how it can affect the interpretation of a measure of association."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe methods used to minimize the effects of confounding and other limitations in pharmacoepidemiologic studies."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Define and interpret effect modification when it occurs."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"List Sir Bradford-­Hill’s considerations for inferring causation from observational data, and describe the difference between causal and spurious associations."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Explain the rationale for meta-­analyses."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe the major elements of a meta-­analysis."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Explain each step involved in a continuous quality improvement process."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Define the term knowledge translation and describe the phases of the knowledge-­to-­action cycle."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe different study designs that are commonly used in pharmacy practice research. Examples will be used to illustrate the advantages and limitations of these different study designs."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Identify the common measures used in pharmacoeconomic studies."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe the major elements of a survey."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Describe common biases that can affect the interpretation of survey data."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Explain how the guiding ethical principles from the Tri-­Council Policy Statement (TCPS) apply when conducting practice based research."
"PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2)","PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16",2017,Winter,"Cross Listed Courses","Pharmacy Practice,",3,"Scot H. Simpson",,4,24,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature."
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Determines appropriate search terms for a given question."
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Uses multiple and appropriate sources to gather information. (e.g. guidelines, primary, secondary and tertiary sources)","1.1.3 competent ","3.1.3 competent "
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Documents and references recommendations where applicable.","3.2.3 competent "
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Critically analyzes information and demonstrates clinical judgment."
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Responds with an appropriate recommendation based on analysis of evidence/information. ","1.1.3 competent ","1.2.3 competent ","1.5.2 functional ","1.9.2 functional ","3.1.3 competent ","3.5.3 competent "
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Under conditions of uncertainty, weighs the pros and cons of alternatives to make decisions; may require preceptor support."
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Logically defends recommendation(s).","1.2.3 competent "
"PHARM 426 (Fall 2016 CLN 800 801)","PHARM 426 Fa16 - EXPERIENTIAL LEARNING Fa16 - PART 4 Combined CLN Fa16",2017,Fall,"Cross Listed Courses","Experiential,",3,"Scot H. Simpson",,0,0,"Facilitates patient’s interaction with the health care system through advice, education and/or guidance with minimal preceptor guidance.","1.2.3 competent ","1.4.2 functional ","1.5.2 functional ","3.3.2 functional ","3.5.2 functional ","3.8.3 competent "
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16,"6.2 Contribute to the development of the care plan","6.3 Contribute to the implementation and monitoring of the care plan","1.1.1 novice ","1.2.1 novice ","1.8.1 novice ","1.11.1 novice ","1.12.1 novice ","3.1.1 novice "
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16,"3.1.1 novice ","1.1.1 novice "
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16,"3.1.1 novice "
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16,"3.1.1 novice ","6.2.3 Immersion -  Evidence informed strategies are proposed and evaluated to address health issues and the patients desired health outcomes"
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 427 (Winter 2017 LEC B1 SEM J1)","PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"John Ussher",,3,16
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Obtain a relevant history from a patient","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CM1 Communicate in a responsible andresponsive manner that encouragestrust and confidence.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CM2 Communicate in a manner that supports a team approach to health promotion and health care.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","LM3 Demonstrate leadership skills.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them.","PR1 Committed to apply best practicesand adhere to high ethicalstandards in the delivery ofpharmacy care.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Explain the anatomy of the heart and great blood vessels.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Develop an appreciation of the interdisciplinary nature of patient care.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CM2 Communicate in a manner that supports a team approach to health promotion and health care.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL1 Work effectively with members ofthe health team including patients,pharmacy colleagues andindividuals from other professions.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2 Hand over the care of a patient toother pharmacy team membersand non-pharmacy team membersto facilitate continuity of safepatient care.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Accept responsibility for keeping abreast of emerging technologies and drugs.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM4.2 Use effective strategies to manage and improve their own practice ofpharmacy.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Apply and demonstrate appropriate counseling and communication with patients","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Follow appropriate monitoring parameters","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC4.1 Provide effective education to others.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","1.1.1 novice ","1.2.1 novice ","1.7.1 novice ","1.8.1 novice ","1.11.1 novice ","1.12.1 novice ","3.1.1 novice ","3.2.1 novice ","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Explain the effects of drugs used in the management of the conditions of primary focus.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe how to manage the toxicity of cardiac medications","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.","3.1.2 functional ","1.1.2 functional ","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Describe the societal and economic impact of the conditions of primary focus","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Identify and locate sources of information needed to solve drug related problems.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Identify ethical issues surrounding treatment of the conditions of primary focus","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Critically evaluate the appropriateness and reliability of information from literature resources.","1.1.1 novice ","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Synthesize information gained from various literature resources to solve problems or make recommendations.","1.1.1 novice ","3.1.2 functional ","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Identify applicable health system resources","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Develop and practice skills for measuring blood pressure and heart rate.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Utilize self-directed learning abilities.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 367 (Winter 2017 LEC B1 SEM J1)","PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",4,"John Seubert",,4,32,"Work effectively in a healthcare team.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","SC4.1 Provide effective education to others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL1.1 Establish and maintain positive relationships.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Identify the basic process requirements in utilizing the Patient Care Process:"
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Apply relevant components of the Patient Care Process model to pharmacy practice."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.","1.2 Establish and maintain professional relationships with patients and colleagues from ones own and other disciplines"
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"a. Construct a patient care database"
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.","1.2.1 novice ","1.7.1 novice ","1.8.1 novice ","1.11.1 novice ","1.12.1 novice ","3.2.1 novice ","3.4.1 novice ","3.5.1 novice ","3.9.1 novice ","4.1 Facilitate effective communication"
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"b. Identify the drug related problem"
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Utilize critical thinking in the problem solving process."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"c. Manage a patient care profile electronically"
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.","2.1.1 novice ","2.2.1 novice ","1.13.1 novice ","1.10.1 novice "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Demonstrate competency of the prescription processing software (KROLL)."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.","2.1.1 novice ","2.2.1 novice "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Function efficiently within the simulated pharmacy, both independently and within a group."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Identify legal requirements when accepting/receiving written & verbal prescriptions.","2.1.1 novice "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Complete an accurate patient record by gathering medication history and other relevant information."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Document search process for drug information questions, citing references used."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Communicate effectively when having a dialogue with a simulated patient and other health care practitioners","1.2.2 functional ","4.1 Facilitate effective communication","4.1.10 Exposure -  Identifies and demonstrates skills for effective verbal communication "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Identify and document potential medication prescribing errors in written and verbal prescriptions.","3.2.2 functional "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Apply concepts of third party billing and prescription pricing in the drug use process. "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Recognize issues surrounding drug diversion and security."
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Demonstrate an introductory level of adverse drug reporting and management.","3.2.1 novice "
"PHARM 342 (Winter 2017 LAB LEC SEM)","PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,7,66,"Relate the concepts of the culture of patient safety to the drug use process."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Explain the anatomy of the female and male reproductive systems.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Develop an appreciation of the interdisciplinary nature of patient care.","2.1 Contribute to the formation and functioning of a collaborative team","6.1 Contribute to the assessment of the patient","1.11.2 functional ","3.4.1 novice ","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the physiology of the female and male reproductive systems.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CL1.3 Join with others in respectful, effective shared decision-making.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Accept responsibility for keeping abreast of emerging technologies and drugs.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","LM2.2 Allocate health care resources for optimal patient care."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","CL1.3 Join with others in respectful, effective shared decision-making.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","LM2.2 Allocate health care resources for optimal patient care.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.","1.1.1 novice ","3.1.1 novice ","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","LM2.2 Allocate health care resources for optimal patient care.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Discuss monitoring parameters for each of the condition of focus.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Utilize self-directed learning abilities.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:"
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Discuss the methods of contraception available for men and women and describe the efficacy of each.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the societal and economic impact of the conditions of focus.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","LM2.2 Allocate health care resources for optimal patient care.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Identify ethical issues surrounding treatment of the conditions of focus.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","PR1.2 Use ethical frameworks as one component of professional judgment."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 499 (Winter 2017 LEC B1 SEM J1)","PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Nese Yuksel",,4,26,"Identify applicable health system resources.","1.6.1 Exposure -  4A2: Available and potential resources are identified ","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","LM2.2 Allocate health care resources for optimal patient care."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Explain their learning and knowledge of nutrition to those who are disease state."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","3.4 Information literacy"
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Discuss dietary management for prophylactic and therapeutic approach of patient care."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Explain the interaction of food and drug."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder)."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases."
"PHARM 327 (LEC B1 Wi17)","PHARM 327 NUTRITION (LEC B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Hoon Sunwoo",,2,21,"Search and report on a topic of relevance to nutrition and health."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.","1.1.2 functional "
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate self-directed learning abilities and team skills."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Accept responsibility of keeping current with emerging therapeutic modalities."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate refinement of critical appraisal, written and oral communication skills.","1.1.2 functional ","1.2.2 functional "
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Incorporate principles of evidence-based medicine into therapeutic decision making.","3.1.2 functional ","1.1.2 functional "
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate a confident and competent approach to solving patient concerns."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings."
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Apply appropriate documentation skills to facilitate care throughout a variety of settings.","3.2.2 functional "
"PHARM 489 (SEM B1 Wi17)","PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17)",2017,Winter,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Sherif Mahmoud",,5,18,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the challenges of providing care in a population with limited evidence."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Use tools to assess medication appropriateness and medication management in seniors."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Be able to triage patients in a community setting and refer them to medical attention as appropriate.","3.2 Accept and make referrals for specific care, expertise and services","3.2.1 Exposure -  The patients signs, symptoms and risk factors that fall beyond ones own scope of practice are recognized.","3.2.2 Immersion -  Identifies appropriate referrals based on patient needs "
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults","2.1 Contribute to the formation and functioning of a collaborative team","6.1 Contribute to the assessment of the patient"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe risks for adverse drug events in pediatric and geriatric patients, and explain why they are more susceptible to adverse events."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify and describe age-appropriate communication strategies.","4.1.3 Integration -  Ensures that knowledge translation occurs at the level of the patient ","1.2.1 novice "
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24," Apply knowledge and skills to establish safe and effective drug use."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the role that culture, religion, and ethnicity may play in health and decision-making."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify controversial health issues involving pediatric and geriatric populations"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify sources of information needed to solve drug-related problems specific to the populations being studied."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Define and be able to use the following terms in a clinical context: geriatrics, gerontology, elderly, aging, frailty."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify and be able to recommend aids to assist in medication management and administration."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe common stereotypes and biases toward aging in our western society."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Empathize with children, older adults, and caregivers regarding challenging decision-making."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24," Explain the demographics of aging, and how that may impact society and the healthcare system."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Prepare and present a personal script to address a controversial topic.","1.2.3 competent "
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Communicate position through oral and written formats.","1.2.3 competent "
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24," List the most common chronic diseases and causes of death in seniors."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Contrast disease presentation between the young adult and the elderly adult."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Define polypharmacy and underutilization in terms of medications in seniors."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Contrast the presentation of adverse events in the elderly compared to the young adult."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the impact of falls on the senior population."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify risk factors for falls in older individuals."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe appropriate interventions for falls."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Contrast how a geriatric syndrome is different than a disease state."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"List the common geriatric syndromes."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Discuss the role of the pharmacist in medication management of seniors."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify methods of appropriately communicating with older adults who are hard of hearing."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the role of the pharmacist in working with home care."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify appropriate home care supports for a given patient."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Categorize the types of abuse commonly suffered by seniors."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the role of the pharmacist in reducing elder abuse"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Discuss the importance of medication safety and identify measures used to ensure safe medication practices"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Discuss basic neonatal care and challenges including premature birth."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Explain how pharmacokinetic parameters are different in infants and children versus adults."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24," Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants, including premature babies, and neonates"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify and discuss appropriate management plans for common pediatric concerns such as teething and fevers."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation)."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Discuss presentation and treatment for common pulmonary pediatric illnesses; croup and bronchiolitis."
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act"
"PHARM 387 (Winter 2017 LEC B1 SEM J1)","PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",1,"Cheryl Sadowski",,5,24,"Discuss the management and implications involved with a diagnosis of autism."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"For the conditions described the student should:"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Explain the anatomy of the integumentary system, eye, ear, nose and throat. "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," obtain a relevant history from a patient."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Work effectively within the healthcare team.","2.1 Contribute to the formation and functioning of a collaborative team"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the physiology of the skin, eyes, ears, nose and throat."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Develop an appreciation of the interdisciplinary nature of patient care","3.1 Understand expertise, roles and responsibilities of IP team members","3.1.10 Exposure -  1B2: Ones own role, nature and scope of practice and the role of others are clearly and concisely described "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Explain the physical conditions that lead to skin breakdown and wound development."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," describe criteria used to make the diagnosis and to be able to relate the severity of the disease."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Accept responsibility for keeping abreast of emerging technologies and drugs."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the physiology of chronic wound healing."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," apply and demonstrate appropriate counseling and communication with patients"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," follow appropriate monitoring parameters"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," recommend appropriate changes to therapy based on patient outcomes and monitoring parameters"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the specific laboratory tests used in the monitoring of isotretinoin."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe and manage the toxicity of medications used in the management of the primary focus conditions"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Describe the societal and economic impact of the primary focus conditions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Manage clinically significant drug interactions with drugs used to treat the primary focus conditions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Identify ethical issues surrounding treatment of the primary focus conditions"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Refer patients to medical attention as appropriate."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Identify applicable health system resources"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation)."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Utilize an evidence-based approach to therapeutic management of the primary focus conditions.","3.1.1 novice "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Apply an evidence-based approach to complementary medicine.","3.1.1 novice "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Evaluate and interpret literature with respect to existing and new dosage forms"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," Identify and locate sources of information needed to solve a problem "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," Critically evaluate the appropriateness and reliability of information from literature resources"
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41," Synthesize information gained from various literature resources to solve problems or make recommendations ","1.1.1 novice ","3.1.1 novice "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Be aware of recent trends in development of new drug delivery systems."
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. "
"PHARM 307 (Winter 2017 LAB LEC SEM)","PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 1st year",2,"Ravina Sanghera-Grewal",,10,41,"Interpret scientific literature to make a clinical recommendation.","1.1.1 novice "
"PHARM 428 (CLN 850 Su16)","PHARM 428 EXPERIENTIAL BLK 2 (CLN 850 Su16)",2017,Summer,"Faculty of Pharmacy and Pharmaceutical Sciences",,8,"Marlene Gukert",,0,0
"PHARM 331 (Winter 2017 LAB LEC SEM)","PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",3,"Raimar Löbenberg/Afsaneh Lavasanifar",,4,59
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Identify the structural features, classification, and life cycle of viral and fungal pathogens.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Given a patient case, complete a patient assessment.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Develop a caring, empathic attitude for patients experiencing the conditions covered.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Describe the etiology, pathogenesis, diagnosis, prevention and treatment (pharmacologic and nonpharmacologic) of various fungal, viral, and protozoal infections as well as sexually transmitted infections. Areas of focus for therapeutic management include: Herpes Simplex Virus, Herpes Zoster, Sexually Transmitted Infections, Viral hepatitis, Influenza, HIV and opportunistic infections, Malaria, Pinworm infections, Protozoal diseases (e.g. Toxoplasmosis, Giardia Lamblia, Cryptosporidium, Amebiasis), Dermatophytoses, Systemic fungal infections (Candidiasis, Cryptococcus)","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Identify actual or potential drug-related problems, develop a therapeutic and monitoring plan taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.","1.1.1 novice ","3.1.1 novice ","3.4.1 novice ","1.6.1 novice ","1.6.1 novice ","1.7.1 novice ","1.8.1 novice ","1.12.1 novice ","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Develop an appreciation for opportunities to engage in the full scope of pharmacy practice as part of patient-centred collaborative care.","1.5.4 Exposure -  Identify the potential benefits of collaboration to meet patients' needs through discussions ","3.1.1 Exposure -  Explores own professional ethical considerations, role and scope of practice in IP contexts ","1.11.1 novice ","1.12.1 novice ","3.4.1 novice ","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Describe the spectrum of action, mechanism of action, mechanisms of resistance, adverse effects, and relevant drug-drug interactions for medications used to treat or prevent various fungal, viral, and protozoal infections.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Document your care for a patient as appropriate (either in a patient health record or community pharmacy records).","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Describe how vaccines stimulate an immune response and provide immunity.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Develop skills necessary for self-directed and life-long learning.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Identify the different types of vaccines (e.g. live attenuated, inactivated) and advantages/disadvantages of each.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Discuss childhood vaccine preventable diseases and the relative risks and benefits of vaccinations.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Describe the composition, dosing, and administration practices of select vaccines administered in adults (e.g. influenza, pneumococcal, hepatitis A, hepatitis B, herpes zoster).","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","HA2.2 Participate in health promotion and disease prevention programs."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Recognize signs and symptoms of adverse reactions that can occur following vaccination and emergency procedures for management.","LM1.2 Contribute to a culture of patient safety.","PR2.2 Demonstrate a commitment to patient safety and quality improvement."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Discuss vaccine hesitancy and effective strategies to address vaccine hesitancy."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Describe the pharmacist’s role in disease prevention and health promotion.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Discuss legal and ethical issues related to vaccinations.","PR1.2 Use ethical frameworks as one component of professional judgment."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Describe prevention and management of Human Blood and Bodily Fluid Exposures (HBBFE).","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents."
"PHARM 477 (Winter 2017 LEC B1 SEM J1)","PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",4,"Christine Hughes",,4,37,"Outline examples of bioterrorism and recognize the etiology, assessment and treatment (e.g.Anthrax, Plague, Tularemia, Arena/Filovirus, Smallpox, Botulism)","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 324 (Winter 2017 LEC SEM)","PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 1st year",1,"Mark Makowsky",,4,23
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify the main anatomical components of the endocrine system.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21," Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe the physiological effects of pituitary, hypothalamic, adrenal, thyroid, parathyroid and pancreatic hormones.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Develop an appreciation of the interdisciplinary nature of patient care.","2.1 Contribute to the formation and functioning of a collaborative team","6.1 Contribute to the assessment of the patient","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Accept responsibility for keeping abreast of emerging technologies and drugs.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.3 Confirm the quality, safety and integrity of products.","LM2.2 Allocate health care resources for optimal patient care."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify and resolve clinically significant drug interactions.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Recognize the main structural features of drugs used to manage endocrine disorders.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Explain the pharmacologic effects of drugs used to manage endocrine disorders.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify and retrieve appropriate sources of information needed to resolve drug related problems.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe the adverse effects of drugs used to manage endocrine disorders.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.","1.1.1 novice ","3.1.1 novice ","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe actions and adverse effects of common natural health products used to manage endocrine disorders.","LM1.3 Confirm the quality, safety and integrity of products.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment, and management of endocrine disorders; including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify ethical and cultural issues surrounding endocrine disorders.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21," Identify the role and the responsibility of the pharmacist within the management of endocrine disorders.","CL2.1 Determine when and how care should be handed over to another teammember.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 497 (Winter 2017 LEC B1 SEM J1)","PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,4,21,"Identify applicable health system resources for the management of endocrine disorders.","1.6.1 Exposure -  4A2: Available and potential resources are identified ","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Demonstrate the EBCP process for answering clinical questions in practice."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Demonstrate the ability to search for and find the best evidence according to the type of question being asked."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Effectively provide a verbal study synopsis."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. "
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Calculate and interpret various estimates of treatment effect."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patient’s medication therapy."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Demonstrate skills in self–directed learning and self-reflection as required for continuous professional development."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Apply verbal and written communication skills important for collaboration in professional team environments."
"PHARM 531 (Spring 2017 LEC A1 A2 SEM E2)","PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Morgan Basiuk",,5,14,"Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice."
"PHARM 547 (Summer 2017 LEC B1 B2 SEM J1)","PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD)",3,"Jill Hall",,9,10,"Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. "
"PHARM 547 (Summer 2017 LEC B1 B2 SEM J1)","PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD)",3,"Jill Hall",,9,10,"Demonstrate respect for diversity of views and experiences."
"PHARM 547 (Summer 2017 LEC B1 B2 SEM J1)","PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD)",3,"Jill Hall",,9,10,"Embrace self-directed and life-long learning."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Describe the role and use of specialized assessments used in patient care."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Apply assessment skills to consistently and efficiently identify and categorize drug therapy problems using a patient care centered approach.  "
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Demonstrate professional attitude and behavior consistently and work collaboratively with other group members."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Demonstrate understanding of normal laboratory and physical assessment findings."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Apply assessment skills to identify opportunities for de-prescribing."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Identify patient assessment issues pertaining to special populations."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Demonstrate refinement of decision making skills in patient assessment."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Demonstrate a systematic approach to performing a physical examination of a patient using inspection and palpation."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Perform vital signs and blood pressure."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Apply physical assessment findings of the following areas to medication monitoring: vital signs, skin, throat, cardiovascular system and respiratory system."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Interpret and convey assessment findings to other providers/clinicians as they relate to pharmacotherapy."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Select and interpret appropriate laboratory tests to monitor drug therapy or screen for untreated conditions."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Assess various symptoms of patients with respect to history, physical and laboratory findings, and potential drug and disease causes."
"PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2)","PHARM 532 Spring 17 - PATIENT ASSESSMENT",2017,Spring,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for BScPharm Students",3,"Dr. Sherif Mahmoud",,5,22,"Apply pharmacokinetic principles to medication monitoring."
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Perform conversions of measurement"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Compute mathematical problems using the following principles; a: density and specific gravity, b: specific volume, c: alligations d: concentrations and dilutions e: isotonic and electrolyte solutions  f: proportions "
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Formulate calculations patient specific parameters and data"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Demonstrate proficiency in using the Aliquot method"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Calculate concentrations of mixtures (weight/weight, weight/volume, volume/weight and volume/volume) and dilutions of stock solutions"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Calculate  concentration and flow rates, infusion times and total volume of IV medications"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Appreciate how pharmacy math contributes to a culture of patient safety"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Develop mathematical knowledge in relation to pharmacy practice; a: fundamentals of pharmaceutical calculations, b: international system of units and pharmaceutical measurement, c: density, specific gravity and specific volume, d: proportions and expressions of concentration, e: calculations relating to the preparation of solutions (isotonic, buffer and electrolyte), f: calculations relating to the delivery of parenteral therapy"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Recognize the variability in measurement and unit conversion"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Recall and arrange mathematical formulas pertaining to pharmacy practice"
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Discuss the fundamental principles of IV therapy (reconstitutions, flow rates, infusion time and total volume) "
"PHARM 341 (LEC A1 Fa17)","PHARM 341 PHARMACY MATH (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Gillian Johnson, Ravina Sanghera",,4,14,"Integrate principles of pharmacy math into a culture of patient safety when relevant."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the clinical presentation and symptomatology of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify and locate sources of information needed to solve drug-related problems","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the long term health consequences of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify presenting symptoms that would be integrated into a triage approach for patients.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the pathophysiology of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:"
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Synthesize information gained from various literature resources to solve problems or make recommendations","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Describe the societal and economic impact of the conditions of primary focus.","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Appreciate the interdisciplinary approach to management of the conditions of primary focus.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Identify ethical issues surrounding treatment of the conditions of primary focus","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Develop an appreciation for advocacy required for individuals with neurologic disorders.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Utilize self-directed learning abilities.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Appreciate the roles of members of the healthcare team in caring for patients with neurologic conditions","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Accept responsibility for keeping abreast of emerging technologies and drugs.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"Summarize the impact on and care for patients with rare neurologic disorders.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 417 (Fall 2017 LEC A1 SEM E1)","PHARM 417 Fall 2017 - NEUROLOGY",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 3rd year",2.5,"Sherif Mahmoud",,3,25,"For each of the conditions described the student should: review the presenting signs and symptoms of the conditions of primary focus, and describe criteria used to make the diagnosis and to be able to relate the severity of the disease; discuss the therapeutic options with peers, including risks and benefits, and medication and alternative therapy choices; recommend appropriate monitoring parameters; recommend appropriate changes to therapy based on patient outcomes and monitoring parameters","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the anatomy of the kidney, ureters, bladder, and urethra.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the physiology of the ureters, bladder and urethra including a general outline of bladder function and micturition.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the physiology of the kidney including regulation of glomerular filtration, sodium/water balance, fluid balance, acid-base balance as well as other electrolytes, tubular reabsorption and secretion.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Explain the major functions and consequences of disturbances of: sodium, potassium, magnesium, calcium, and phosphate.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the pathophysiology of renal disorders including acute kidney injury, chronic kidney disease, nephrolithiasis, and incontinence including clinical presentation and symptomatology and long term health consequences","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the epidemiology, etiology, and risk factors of the following: renal disorders including acute kidney injury, nephrolithiasis, Chronic Kidney Disease, and LUTS.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Explain and interpret pertinent serum chemistry laboratory values, as well as specific laboratory tests used in the diagnosis and monitoring of acute kidney injury, chronic kidney disease, nephrolithiasis, and lower urinary tract symptoms (LUTS).","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS including use of specific target drugs for the condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Explain the effects of drugs used in the management of electrolyte disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify medications which can cause renal toxicity, and describe the appropriate management."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the principles of the various Renal Replacement Therapies (Hemodialysis, Peritoneal Dialysis, and Continuous Renal Replacement Therapy). "
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe the societal and economic impact of LUTS"
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Assess fluid balance based on medical history as well as presenting signs and symptoms, and recommend appropriate management of the patient.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Calculate creatinine clearance and adjust doses for medications that are renally eliminated.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify the presenting signs and symptoms of electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS and describe criteria used to make the diagnosis.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Assess lab data in order to manage medical condition and medication regimen.  ","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Discuss the therapeutic options, including risks and benefits, and medication and alternative therapy choices.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify appropriate monitoring parameters.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of electrolyte disorders (hyper/hyponatremia, hyper/hypokalemia), acid-base disorders, acute kidney injury, chronic kidney disease nephrolithiasis, and LUTS.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Describe how to triage a given patient in a community setting and identify when to refer them to medical attention as appropriate.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","PR2.1 Take responsibility and accountability for actions and inactions.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Design pharmaceutical care plans including alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with electrolyte disorders, acute kidney injury, nephrolithiasis, and LUTS","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"For each of the conditions described the student should:"
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Accept responsibility for keeping abreast of emerging technologies and drugs","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus. ","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Work effectively within the healthcare team.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","PR2.1 Take responsibility and accountability for actions and inactions.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Develop an appreciation of the interdisciplinary nature of patient care.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27," Identify actual and potential drug-related problems relating to electrolyte disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS in patient cases.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify and locate sources of information needed to solve drug-related problems ","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Utilize an evidence-based approach to therapeutic management of electrolyte disorders, acid-base disorders, acute renal failure, chronic kidney disease, nephrolithiasis, and LUTS.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Identify actual and potential drug-related problems relating to electrolyte disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS in patient cases.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",2,"Ravina Sanghera",,5,27,"Explain the interdisciplinary approach to acute kidney injury, chronic kidney disease nephrolithiasis, and LUTS management."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"Following this course, students should be able to interpret the labels on radiopharmaceuticals; perform simple calculations related to radioactive decay.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To illustrate the rationale for the use of radioactive drugs and contrast agents for diagnosis by discussing: the various agents presently available from commercial suppliers; the physiological basis of their utility and clinical applications; their formulation and manufacture; methods of quality control and dispensing and inventory control. The use of radioactive drugs for therapy will be examined.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To illustrate ""radiopharmaceutical kits"", and radionuclide generators for daily preparation of short-lived radiopharmaceuticals in a hospital.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation – toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"This course will provide pharmacists with fundamental knowledge of contemporary clinical imaging modalities, including the use of radiopharmaceuticals and contrast agents in clinical diagnosis and therapy. Such a basic understanding will enable pharmacists, as members of a Health Team, to communicate knowledgeably with physicians, nurses, technicians and patients regarding the use of various imaging techniques. Emphasis will be placed on radiopharmaceuticals and contrast agents used with these procedures. The use of radioactive materials for in vitro and in vivo tests, and for radiation therapy, will be addressed. An understanding of the general principles underlying the biologic effects of various levels of radiation will assist the pharmacist in allaying patients' fears and misapprehensions regarding radioactivity.","CL1.3 Join with others in respectful, effective shared decision-making.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk – benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 311 (LEC A1 Fa17)","PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",1,"Arno G. Siraki",,4,14,"This course will provide a basis for further training (either formally or on-the-job) which will provide the expertise for safe and effective handling, preparation and dispensing of radiopharmaceuticals and maintaining proper quality control and inventory.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence."
"PHARM 304 (Fall 2014 LAB LEC SEM)","PHARM 304 Fa14 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa14",2017,Fall,"Cross Listed Courses",,3,"Arno G. Siraki",,0,5
"PHARM 301 (LEC A1 Fa17)","PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Carlos A. Velázquez",,2,39,"Given a chemical structure, students should be able to describe: (a) The acid/base properties of a drug molecule; (b) the water and lipid solubility of drug molecules; (c) which functional groups are more likely to be metabolized (chemical stability) by the body; (d) the stereochemical properties of drug molecules; (e) possible drug-drug and drug-food interactions.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 301 (LEC A1 Fa17)","PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Carlos A. Velázquez",,2,39,"Students should be able to explain, at a molecular level: (a) The principles governing the absorption, distribution, metabolism, excretion, and elimination of drugs; (b) the main biochemical pathways by which the human body metabolizes drugs.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems."
"PHARM 301 (LEC A1 Fa17)","PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Carlos A. Velázquez",,2,39,"Students should be able to describe, at a molecular level: (a) The types and bonding strengths exerted by drug molecules on biological targets (i.e. receptors or enzyme binding sites); (b) drug-receptor binding interactions and their relationship with the exerted pharmacologic activity; (c) the mechanisms of action by which drugs exert therapeutic and/or adverse effects; (d) the correlation between metabolic transformations and drug pharmacodynamics.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 301 (LEC A1 Fa17)","PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Carlos A. Velázquez",,2,39,"Students should be able to describe, at a molecular level, the physicochemical properties of drugs determining: (a) routes of administration; (b) commercial drug formulations (this will be complementary to the course “Pharmaceutics I”).","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems."
"PHARM 301 (LEC A1 Fa17)","PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Carlos A. Velázquez",,2,39,"The concept of ""prodrug""; the most common types of prodrugs used in clinic.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Outline the epidemiology, etiology, pathophysiology, and clinical presentation of the disease states covered, including: hypertension, cardiovascular risk reduction (dyslipidemia, obesity), heart failure, atrial fibrillation & stroke, diabetes, COPD, pain, depression/anxiety, arthritis, infectious diseases (pneumonia), selected oncology related complications, and selected geriatric medicine topics."
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Demonstrate an understanding of key concepts in pharmacokinetics and therapeutic drug monitoring and apply pharmacokinetic principles to resolve drug therapy problems and optimize pharmacotherapy outcomes."
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Apply acquired therapeutic knowledge to confidently and competently manage medication therapy (including monitoring and follow-up) for patients with both the common disease states covered and those beyond, even if complex interplay between disease states exists. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Demonstrate critical thinking, therapeutic knowledge, and the use of a therapeutic thought process (patient care process) in prioritizing and resolving a patient’s drug related problems, making appropriate recommendations related to ambiguous medication-related issues and those where evidence is limited or contradictory. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Demonstrate the ability to research, critically appraise, and apply primary literature and clinical practice guidelines in the management of patients with a variety of disease states, consistently and efficiently integrating new knowledge into your therapeutic schema. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Develop and defend a detailed care plan (with supporting chart documentation) to resolve and/or prevent drug related problems, applying principles of evidence-based medicine. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Effectively translate therapeutic knowledge to patients with complex care issues and/or those of a sensitive nature that present challenges in communication, in a variety of settings. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Demonstrate the self-directed learning, self-reflection, and peer assessment skills required for continuous professional development and precepting students. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Apply the communication, collaboration, and leadership skills gained through teamwork to other professional team environments."
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients’ pharmacotherapy outcomes. "
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Demonstrate respect for diversity of views and experiences."
"PHARM 503 (Fall 2017 LEC A1 SEM E1)","PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",6,"Jill Hall",,8,34,"Embrace self-directed and life-long learning. "
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2 Integrate best availableevidence into pharmacypractice.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Comprehend concepts related to nonlinear elimination of drug.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 351 (LEC A1 Fa17)","PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Dr. Dion Brocks",,4,36,"Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Describe the pathophysiology of common malignancies including clinical presentation and symptomology and long term health consequences."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Explain the effects of drugs used in the management of cancer."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Describe the specific laboratory tests used in the diagnosis and monitoring of malignancies."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Describe and manage the toxicity of medications used in the management of the conditions of primary focus."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Describe the societal and economic impact of the conditions of primary focus."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Appreciate the interdisciplinary approach to management of malignancies."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Identify ethical issues surrounding treatment of malignancies, including palliative care."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy."
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Identify applicable health system resources (for example drug interaction databases)"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Be able to do basic calculations (e.g. routine lab tests)"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Understand self-assessment for e.g. skin cancer"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Be able to explain frequencies and age-ranges for cancer screening"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Understand and explain drug-drug interactions for chemotherapeutics and other medications (e.g. treatments for side-effects, medications for co-morbidities, CAMs, etc)"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Be able to plan opioid and methadone rotations for palliative care"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Know how to do mental estimation to prevent drug administration errors"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Know the resources for preventing/reporting drug administration errors"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Know how to respond to an oncology emergency"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Understand the patient perspectives of their diagnosis and treatment"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Develop a caring, empathic attitude for patients battling various kinds of cancer"
"PHARM 467 (Fall 2017 LEC A1 SEM E1)","PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",2,"Dr. Victor Samokhvalov",,2,21,"Understand the difference between physical and psychological addiction, specifically related to fears of patients undergoing palliative care."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Describe the types of information found in some common pharmacy tertiary and secondary reference sources."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Identify the functions and services offered by the health sciences library."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Use library resources and library facilities effectively to access relevant drug information. "
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Obtain relevant background information from the client about the patient, disease, and/or drug."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Demonstrate a systematic step-wise approach to answer drug information requests."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Identify strengths and weaknesses of the secondary and tertiary resources commonly used. "
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Determine the depth of response required for any given question. "
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Follow-up on drug information requests where appropriate."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Apply legal and ethical principles to issues that may occur in practice."
"PHARM 304 (Fall 2017 LAB LEC SEM)","PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",0.5,"Ken Cor",,3,18,"Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Discuss and contrast theories of groups"
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Describe elements of group development, group dynamics, and group effectiveness."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Apply principles of program evaluation to plan and evaluate a group experience."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Discuss and contrast theories of learning including: behavioral, cognitive, humanist, social cognitive, constructivist, critical."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Develop education plans using principles of needs assessment, planning, development, and evaluation for diverse audiences including professionals, public, patients and groups of patients."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Present information and views effectively in written and oral presentation formats."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Apply critical thinking skills."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Facilitate professional learning."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Demonstrate respect for diversity of views and experiences."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Demonstrate self-directed and life-long learning."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Examine the relevance of learning styles in the education of professionals."
"PHARM 524 (LEC 800 Fa17)","PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",1,"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,4,6,"Demonstrate collaboration in learning."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate self-directed learning abilities and team skills."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Accept responsibility of keeping current with emerging therapeutic modalities."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate refinement of critical appraisal, written and oral communication skills."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Incorporate principles of evidence-based medicine into therapeutic decision making."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate a confident and competent approach to solving patient concerns."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Apply appropriate documentation skills to facilitate care throughout a variety of settings."
"PHARM 489 (SEM A1 Fa17)","PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences",,3,"Tony KL Kiang",,5,12,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations."
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Recognize the role and use of other specialized assessments used in patient care. "
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Identify and synthesize key concepts, processes, and relationships of pharmacy practice, patient assessment, care plan development and documentation"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Recognize normal physical assessment findings"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Utilize the following patient care skills: Physical assessment skills where appropriate; Assessment of other patient data (laboratory data); Documentation/communication of assessment "
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Consistently and efficiently identify and categorize drug therapy problems in a given patient scenario "
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Demonstrate a systematic approach to performing a physical examination of a patient using all four modes of assessment: Inspection, Palpation, Percussion, Auscultation"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Perform vital signs and blood pressure measurements"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Apply physical assessment findings of the following areas to medication therapy management: Vital signs, Skin, hair, nails, Head, ears, eyes, nose and throat, Cardiovascular system, Respiratory system, Peripheral vascular system, Nervous system, Musculoskeletal system"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Interpret and convey assessment findings to other providers/clinicians as they relate to pharmacotherapy"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Select and interpret appropriate laboratory tests to monitor drug therapy or screen for untreated conditions"
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Assess various symptoms of patients with respect to history, physical and laboratory findings, and potential drug and disease causes."
"PHARM 502 (Fall 2017 LAB D1 LEC A1)","PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Dr. Rene Breault",,5,28,"Validate the importance of physical exam findings for the purpose of assessing and monitoring drug therapy"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Develop an understanding of the role and expectations of experiential learning in the curriculum "
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Explore the understanding of professionalism as the ability to identify and negotiate the expectations of others"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Demonstrate critical thinking and reflection to optimize learning from experience and care for clients"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Develop the ability to build collaborative relationships with clients and staff"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Explore how the critical thinking/reflective practice of person-centred care in Pharm 300 relates to the reflective practice of client centered care in pharmacy"
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Demonstrate initiative in service and learning "
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Practice in an ethical manner to assure primary accountability to the client "
"PHARM 300A (Fall 2017 LEC C1 SEM E1 E2)","PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Masters of Science",1,"Cheryl Cox",,7,7,"Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Describe the types and organization of muscles."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Understand basic processes governing pharmacokinetic behaviour of drugs."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"List seven basic classes of disease based on disease mechanisms, and give examples."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Discuss the molecular and cellular events underlying the different classes of disease."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Correlate drug therapy with disease mechanisms for representative major diseases."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Anatomy: Describe cell structure, cell function and tissue types"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Physiology: Describe body composition, body fluids, and fluid compartments."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Describe lysosomal function, membrane function and membrane transport."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Explain resting potential."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Describe membrane transport."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Describe action potential"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Explain how the various sensory mechanisms function."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Describe nerve conduction and neuromuscular and synaptic transmission."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Define the types of toxins which create problems in the environment."
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Explain the mechanism of toxicity of individual toxins which cause problems in the environment"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Describe hazard identification and assessment methods"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Determine dose-response assessment"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Determine exposure assessment"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Examine applicable Canadian and American legislation governing environmental discharge. Understand where forensic toxicology is used "
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Understand and use medical terminology related to disease, to a degree sufficient to understand the pathophysiology content in the subsequent blocks"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Understand toxicity and safety assessment of natural health products"
"PHARM 306 (LEC A1 Fa17)","PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2.5,"Ayman El-Kadi",,2,21,"Toxicology: Understand basic toxicological concepts, and the different areas of toxicology."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Formulate an answerable (i.e., focused) question."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Demonstrate an ability to search online databases including synthesized sources for the best evidence."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Critically appraising various types of evidence for validity, clinical relevance, and applicability."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Apply evidence to clinical situations while individualizing recommendations based on clinical expertise and patient values."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Evaluate the effectiveness and efficiency of your educational process."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Demonstrate the EBCP process for answering clinical questions in practice."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Formulate focused clinical questions using the PICO approach in the domains of Therapy, Harm, Prognosis, Diagnosis and Harm."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Describe available resources according to the 6S hierarchy of pre-appraised evidence and demonstrate the ability to search these resources to find the best evidence according to the type of question being asked."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Compare, contrast and hierarchically categorize the most commonly encountered study designs by pharmacists in clinical practice according to the type of question being asked."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Effectively provide a verbal study synopsis."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability.  "
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Calculate and interpret various estimates of treatment effect."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patient’s medication therapy."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Demonstrate skills in self–directed learning and self-reflection as required for continuous professional development."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Apply verbal and written communication skills important for collaboration in professional team environments."
"PHARM 501 (Fall 2017 LEC A1 SEM E1)","PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Mark Makowsky, BSP, PharmD, ACPR",,5,23,"Confidently and competently teach a group of health care professionals about a discrete concept relevant to EBCP."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacist’s role in compounding.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Apply appropriate parenteral technique in clinical situations.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Apply knowledge of sterility requirements","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Explain how to maintain a clean work environment","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Explain importance of quality of ingredients including bioburden","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Identify risks of cross contamination in a laminar flow work bench","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Explain importance of monitoring programs and training of personnel","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Apply modern pharmacopeia standards and methods to assess the quality of dosage forms","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","SC2 Integrate best availableevidence into pharmacypractice.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC3 Contribute to the creation ofknowledge or practices in thefield of pharmacy.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Demonstrate appropriate documentation practices in compounding.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Perform compounding and packaging of drug products in small quantities according to legal and professional standards","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Evaluate the stability and the shelf life of drugs under different storage conditions","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Conduct quality control of the final product","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Identify and locate sources of information needed to solve a problem related to Pharmaceutics","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2 Integrate best availableevidence into pharmacypractice.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3 Contribute to the creation ofknowledge or practices in thefield of pharmacy.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2 Integrate best availableevidence into pharmacypractice.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3 Contribute to the creation ofknowledge or practices in thefield of pharmacy.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry.","SC4.1 Provide effective education to others.","SC4.2 Employ appropriate teaching roles when teaching others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers.","SC4 Teach other pharmacy teammembers, the public andother health careprofessionals includingstudents."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics","SC4.1 Provide effective education to others.","SC4.2 Employ appropriate teaching roles when teaching others.","SC4.3 Deliver effective feedback in teaching and learning situations.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2 Integrate best availableevidence into pharmacypractice.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3 Contribute to the creation ofknowledge or practices in thefield of pharmacy.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry.","SC4 Teach other pharmacy teammembers, the public andother health careprofessionals includingstudents.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Perform aseptic compounding techniques","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Evaluate various sterilization methods","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Develop standard operation procedures","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Apply knowledge of a quality assurance program for sterile compounding","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Evaluate risk levels","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","SC1 Apply medication therapyexpertise to optimizepharmacy care, pharmacyservices and health caredelivery.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Set up an aseptic work environment and maintain the quality of the work environment","LM1 Contribute to optimizing healthcare delivery and pharmacyservices.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.2 Contribute to a culture of patient safety.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1)","PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",3,"Afsaneh Lavasanifar",,4,46,"Be aware of recent trends in development of new drug delivery systems","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Demonstrate an awareness of the evolving practice environment of pharmacy.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Demonstrate an understanding of the concept of professionalism ","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Understand the pharmacy regulatory bodies in Canada ","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Identify basic concepts, principles, and components of health care delivery and the health care system in Canada and the province of Alberta. ","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Summarize the patient care process and how it relates to the pharmacist’s role in the health care system. ","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Understand the interprofessional learning pathway and roles of students in other health professions ","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Understand the role of Complementary and Alternative Medicine providers in the health care system and how pharmacists can collaborate with them to optimize patient care and safety.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Discuss the payment model within the realm of pharmacy ","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Demonstrate an understanding of the concepts and principles of Health and Health Promotion.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","HA2.2 Participate in health promotion and disease prevention programs."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Describe the role of health behaviour theory in pharmacy practice. ","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Describe, compare and contrast the impact of the social determinants of health","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Describe the historical development of pharmacy through trends that have led to the current practice philosophy.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Describe the role of theory in health care","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Apply introductory knowledge of the health care system for solving problems in practice.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Apply the patient care process to solve problems","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Demonstrate appropriate writing skills at post-secondary level.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Apply theories of patient behaviours to identify methods of intervention for treatment outcomes.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Analyse your own personal health beliefs and how they impact your clinical decision making process.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Integrate knowledge from various sources/activities with respect to pharmacy practice.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Appreciate the pharmacist as a member of the health care team ","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Appreciate and show respect for the shared and unique roles of the professions, as well as Complementary and Alternative Medicine providers.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"*I do not explicitly evaluate attitudes, but have included them for your information. "
"PHARM 322 (LEC A1 Fa17)","PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Chowdhury Farhana Faruquee",,4,38,"Discuss the responsibilities pharmacists have with respect to their role in a health care team.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Describe the epidemiology, etiology, pathophysiology, and clinical presentation of the disease states covered in the course, including: hypertension, cardiovascular risk reduction (dyslipidemia, obesity), heart failure, venous thromboembolism, diabetes, infectious diseases (pneumonia), and selected oncology-related complications (febrile neutropenia, chemotherapy-induced nausea and vomiting)."
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Demonstrate an understanding of key concepts in pharmacokinetics and therapeutic drug monitoring and apply pharmacokinetic principles to resolve drug therapy problems and optimize pharmacotherapy outcomes."
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Apply acquired pharmacotherapy knowledge to be able to confidently and competently manage drug therapy (including monitoring and follow­-up) for patients with the common disease states covered in the course and those beyond, even if complex interplay exists between disease states.   "
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Demonstrate pharmacotherapy knowledge, critical thinking, and the use of a therapeutic thought process (patient care process) in prioritizing and resolving patients' drug therapy problems, making appropriate recommendations related to ambiguous medication-related issues, including those where evidence is limited or contradictory.  "
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Develop and defend a detailed pharmacy care plan (with supporting rationale) to resolve and/or prevent drug therapy problems, applying principles of evidence­-based medicine."
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Demonstrate the ability to research, critically appraise, and apply primary literature and clinical practice guidelines when managing medication therapy in patients with a variety of disease states, consistently and efficiently integrating new knowledge into your therapeutic schema.  "
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients’ pharmacotherapy outcomes."
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Effectively apply pharmacotherapy knowledge to patients with complex care issues and/or those of a sensitive nature that present challenges in communication, in a variety of settings. "
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Demonstrate the self-­directed learning, self­ assessment, and peer­ assessment skills required for continuous professional development and precepting students.  "
"PHARM 523 (Fall 2017 LEC 800 801)","PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17",2017,Fall,"Cross Listed Courses","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time)",3,"Sarah Woodworth-Giroux",,5,8,"Develop effective communication, collaboration, and leadership skills gained through teamwork."
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Apply communication techniques for monitoring medications "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Engage in respectful, empathetic, compassionate, non-judgmental, culturally safe, tactful conversations with patients and health team members."
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Accept responsibility for communicating professionally through both student and professional career "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Explain the importance of stress management in professional life"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Engage in effective partnerships with their patients to support positive behaviour changes"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Advocate for pharmacists role in monitoring medication therapy at the medication refill"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Foster curiosity to understand and appreciate patients unique life experience"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Compare and contrast concordance, compliance, and adherence frameworks "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Compare and contrast intentional and unintentional medication taking behaviours "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Communicate effectively with people with vision, hearing loss or who are using a translator"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Apply the Three Talk model to make a shared decisions"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Describe the elements of a medication history"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Select and integrate communication techniques to effectively communicate risk to patients"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Differentiate strategies to communicate with patients with vision and hearing loss. "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Establish organization and flow while taking a full medication history","1.2.3 competent ","1.5.3 competent ","1.6.3 competent ","1.11.3 competent ","1.12.3 competent ","3.5.3 competent ","3.2.3 competent ","4.1.2 Immersion -  Matches level and mode of communication to the needs of team members (patient, family, health professionals)","4.1.7 Exposure -  Explores the level and mode of communication preferred by team members (patient, family, community, health professionals) "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Identify communication challenges associated with providing care to a patient whose first language is not English. "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others."
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Outline effective patient education skills"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20," Practice self-care activities to manage stress in professional life"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Describe the appropriate process for working with an interpreter in a healthcare setting. "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Define shared decision making and differentiate it from other decision making models.","4.1.3 Integration -  Ensures that knowledge translation occurs at the level of the patient "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20," Detect and address barriers to patients medication taking behaviors using supportive probing techniques "
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Identify several strategies for effectively communicating risk"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20," Provide timely, clear responses that are tailored to the context and audience."
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Select and integrate communication techniques to effectively communicate with other healthcare professionals.","4.1.2 Immersion -  Matches level and mode of communication to the needs of team members (patient, family, health professionals)"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Reflect on communication skills"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Explain a process to manage emotional consults"
"PHARM 334 (Winter 2017 LEC B1 SEM J1 J2)","PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17",2017,Winter,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Lisa Guirguis",,4,20,"Identify core principles and key skills of motivational interviewing"
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Relate core beliefs about teaching and learning to educational experiences."
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Discuss, contrast, and apply theories of learning including:  behavioural, cognitive, humanist, social cognitive, constructivist, and critical frameworks."
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Discuss the role of feedback  related to preceptorship of pharmacy students."
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Design, deliver, and evaluate education plans using theoretical frameworks "
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Examine the application of learning styles in the education of professionals. "
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Apply theoretical frameworks for collaboration and  groups. "
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Explore current issues on collaboration: teamwork, leadership, communication. "
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Present information and views effectively in written and oral presentation formats."
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Apply reflective and critical thinking skills. "
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Facilitate student and professional learning."
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Demonstrate respect for diversity of views and experiences. "
"PHARM 504 (LEC A1 Fa17)","PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time)",3,"Terri Schindel",,4,13,"Demonstrate appreciation for self-directed and life-long learning."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the conditions of primary focus, including use of specific target drugs for condition as well as complementary and alternative therapies"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Develop an appreciation of the interdisciplinary nature of patient care."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the societal and economic impact of the conditions of primary focus."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Discuss monitoring parameters for each of the disease of focus"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Accept responsibility for keeping abreast of emerging technologies and drugs."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Explain the anatomy of the gastrointestinal tract; describe the functions of the gastrointestinal tract.  "
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Explain the anatomy of the liver; describe the functions of the liver . "
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Utilize self-directed learning abilities."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. "
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Discuss drugs that can be toxic to the liver"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Antidiarrheals ii. Laxatives iii. Antinauseants iv. Antiemetics v. Antacids vi. Anti-gas vii. Antispasmodics viii. Drugs Stimulating Gastrointestinal Motility (Prokinetic Agents) ix. Proton-Pump Inhibitors x. H2 receptor antagonists xi. Mucosal protective agents Sucralfate, Prostaglandin analogs (ie misoprostil), Colloidal Bismuth Compounds xii. Antibiotics used for PUD xiii. Aminosalicylates xiv. Corticosteroids used in IBD xv. Immunosuppressants used in IBD (including azathioprine, 6-mercaptopurine, cyclosporine, methotrexate) xvi. Tumour necrosis factor – alpha antagonists (infliximab, adalimumab, certolizumab, golimumab) xvii. Pharmacotherapy for complications of cirrhosis (ie diuretics, spironolactone, beta-blockers, octreotide, lactulose, and metronidazole)"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the treatment options for oral health such as canker sores, dry mouth, and mouth care."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Discuss the types of ostomy supplies used by patients with ostomies"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Discuss the complementary and alternative medicine used in GI diseases."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Describe the specific laboratory tests and other diagnostic tests used in the diagnosis and monitoring of the conditions of primary focus."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the conditions of primary focus."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Appreciate the interdisciplinary approach to management of the condition"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Identify ethical issues surrounding treatment of the conditions of primary focus"
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy."
"PHARM 357 (Fall 2017 LEC A1 SEM E1 E2)","PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,",2,"Terri Schindel",,4,25,"Identify applicable health system resources."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Describe the impact of communication in health and health care "
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Explain the importance of communication in the practice of pharmacy"
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Explain the link between effective communication skills and patient care ","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Understand the importance of listening","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Understand the meaning of a patient-centred care","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Understand the impact of empathetic responding in patient-provider interactions ","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Recognize the difference between aggressive, passive, and assertive communication ","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Define a medication experience","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Describe the importance of a patient's’ medication experience","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Describe the health care experiences of low-literacy patients","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Discuss health literacy and medication ","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Review techniques to improve communication with low-literacy patients","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Identify different types of question asking","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Discuss the link between reflection and lifelong learning ","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Identify appropriate uses of social media in health care","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Demonstrate effective public speaking and presentation skills","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Write in a clear and concise manner using the rules of grammar and punctuation","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Work effectively in groups","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Offer and receive constructive feedback","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Demonstrate professional communication","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Critically reflect on communication in patient care","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Tailor communication to specific contexts and audiences","CM1.2 Provide timely, clear responses that are tailored to the context andaudience."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Write data section of a clinical documentation note after a standardized patient encounter","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Introduce self and identify patient","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Use small talk to establish rapport","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Solicit the full patient agenda ","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Use appropriate question style","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Use active listening skills to explore the patient experience and concerns","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Gather sufficient information to evaluate medication appropriateness","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Identify and name patient feelings (i.e., empathetic responding) ","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Demonstrate effective non-verbal communication skills","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Establish flow and organization in a patient encounter","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Display confidence in a patient encounter","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Appreciate the patient’s experience and perspective in health care ","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Accept responsibility for communicating professionally through both student and professional career ","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality."
"PHARM 314 (Fall 2017 LAB LEC SEM)","PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",1,"Chowdhury Farhana Faruquee",,6,24,"Value reflection and its role in lifelong learning","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe the standards of practice guiding administration of drugs by injection.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","LM1.3 Confirm the quality, safety and integrity of products."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Be proficient in expressing empathy towards patients,","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe a system for administering and recording injections.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM1.3 Confirm the quality, safety and integrity of products."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Communicate with patients with low health literacy, who are poor historians, who are resistant to care, who are emotional (sad, angry, or unpredictable), who have experienced poor outcomes andwho are at end of life.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38," Describe the principles of asepsis (e.g. handwashing, use of gloves, preparing injectable drugs, preparing injection site, injecting medications and vaccines, disposing of syringe/needle andswabs).","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM1.3 Confirm the quality, safety and integrity of products."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Present a complex patient case to a healthcare practitioner audience and practice patient presentation skills with focus on presenting the care plan for in a clear, concise, and logicalmanner.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe criteria used to select an appropriate needle and syringe for injections/immunizations","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM1.3 Confirm the quality, safety and integrity of products."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Be proficient in clinical documentation (data, assessment, plan)","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe how to withdraw medication from an ampoule/vial","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM1.3 Confirm the quality, safety and integrity of products."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Research and respond to advanced level drug information questions.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe the principles and steps of the patient care process.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","HA1.2 Work with patients to increase opportunities to adopt healthybehaviours.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients.","LM2.2 Allocate health care resources for optimal patient care.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Initiate prescription therapy.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe essential elements of clinical documentation.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Modify prescription therapy based on patient assessment and response.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Discuss the characteristics and importance of the therapeutic relationship with a patient.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","HA1.3 Incorporate disease prevention, health promotion and health surveillanceinto interactions with individual patients."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Apply Chronic Disease Management concepts and encourage patient selfmanagement of chronicdisease.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:"
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Recognize unique aspects of care for minor ailments for pharmacists as compared to management of other medical conditions.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Identify and resolve Drug Related Problems for patients presenting with multiple conditions.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Identify challenges in interprofessional collaboration and strategies to overcome them.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Appropriately transfer care of a patient to another pharmacist, including transfers between institutionalandcommunitybasedcare.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Appropriately manage patient care in a patient care team with other health professionals.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL2.1 Determine when and how care should be handed over to another teammember.","LM1.2 Contribute to a culture of patient safety.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Appropriately refer patients to another health care professional.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL2.1 Determine when and how care should be handed over to another teammember.","LM1.2 Contribute to a culture of patient safety.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Administer medications by injections.","LM1.3 Confirm the quality, safety and integrity of products.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Identify a strategy to meet the requirements for obtaining advanced prescribing authorization when eligible.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Complete a patient assessment (building a patient database and elicit relevant information)","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Complete a pharmacotherapy workup including drug therapy assessment, interventions, education and monitoring and follow up.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Demonstrate patient-centred communication"
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Demonstrate evidence-based decision making","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Engage in meaningful selfreflection","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Prepare medications for injection; demonstrate location of appropriate sites for various types of injections; and demonstrate appropriate technique when giving intradermal, subcutaneous, and intramuscular injections","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM1.3 Confirm the quality, safety and integrity of products."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Develop an approach to cognitive assessment in the elderly","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe the key steps involved in administering a naloxone injection."
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Describe the communication tools and resources available to identify and assist a patient in distress or crisis. "
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Function as a team member/leader of an interprofessional team during laboratory group activities"
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Assume the role of the pharmacist in each of the lab activities and take responsibility and accountability"
"PHARM 430A (Fall 2017 LAB LEC)","PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",3,"Candace Necyk, Teri Charrois, Gillian Johnson",,6,38,"Display professional attitude as outlined in professionalism expectations"
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Select and monitor drug therapy for the conditions of primary focus by applying concepts and knowledge of medicinal chemistry, pharmacology, pharmacokinetics and therapeutic principles."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.","PR1 Committed to apply best practicesand adhere to high ethicalstandards in the delivery ofpharmacy care.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Explain the anatomy of respiratory system and relation to function.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow-up for patients with the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Exemplify professionalism throughout all course activities by adhering to professionalism standards outlined in the course, the ACP and university policies","CL1 Work effectively with members ofthe health team including patients,pharmacy colleagues andindividuals from other professions.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the physiology of respiration including lung volumes, capacities, lung function (gas exchange), ventilation/perfusion, mechanisms of breathing and control of breathing","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Identify actual and potential drug-related problems relating to conditions of primary focus in various patient cases.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Develop an appreciation of the interdisciplinary nature of patient care","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the principles of medicinal chemistry relevant to the conditions of primary focus","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the principles of pharmacology relevant to the conditions of primary focus","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Identify drugs and environmental agents that may cause pulmonary adverse events","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe patterns of response in the respiratory system to drugs and environmental agents that may cause pulmonary adverse events and management approaches.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Notice signs that require patients to be triaged from a community setting to receive medical attention as appropriate.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CL2.1 Determine when and how care should be handed over to another teammember."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Explain the effects of drugs used in the management of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CL2.1 Determine when and how care should be handed over to another teammember."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the nature of nicotine dependency and the risks associated with tobacco use","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Counsel on the use of inhalers, and devices (valved holding chambers and peak flow meters).","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the methods and tools available for assisting motivated patients with smoking cessation","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:"
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the pharmacokinetics and pharmacodynamics of smoking","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Critically evaluate the appropriateness and reliability of information from literature resources","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the specific laboratory or functional tests used in the diagnosis and monitoring of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Using an evidence-based approach, synthesize information gained from various literature resources to solve problems or make recommendations for the therapeutic management of the conditions of focus.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe the therapeutic approach (Clinical Practice Guidelines) incorporating non-pharmacologic and pharmacologic treatments for the prevention, treatment and management of the conditions of primary focus including the use of specific target drugs for condition as well as alternative therapies (dose, route of administration, duration of therapy, monitoring parameters for efficacy and toxicity)","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Describe and manage the toxicity of medications used in the management of the conditions of primary focus.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents."
"PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, 2nd year",2,"Renette Bertholet",,6,29,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Understand the process of medication reconciliation and seamless care, and how it applies to transitions of care","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Apply the patient care process to patients presenting to a community pharmacy and hospital setting including: create a patient database by gathering appropriate patient related information; assess a patient for an allergy, drug intolerance or adverse effect; assess a patient's relevant physical findings in order to evaluate drug therapy; assess a patient for non-adherence and develop a plan; identify, resolve and monitor patients with drug-related problems; determine appropriateness to adapt prescriptions, recommend changes to therapy, initiate therapy for minor ailments, and/or refer to physicians; prioritize drug-related problems; and, provide rationale for clinical decision-making","PR1 Committed to apply best practicesand adhere to high ethicalstandards in the delivery ofpharmacy care.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","CP1 Practise within the pharmacist scope of practice and expertise.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.2 Integrate AFPC Communicator, Collaborator, Leader-Manager, Health Advocate, Scholar and Professional roles in their practice of pharmacy.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2 Provide patient-centred care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CM1 Communicate in a responsible andresponsive manner that encouragestrust and confidence.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CM2 Communicate in a manner that supports a team approach to health promotion and health care.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","LM1.2 Contribute to a culture of patient safety."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,Function as a team member/leader of an interprofessional team during laboratory group activities,"LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems.","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Describe the steps of a minor ailments assessment and assess when to refer a patient","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","HA1.2 Work with patients to increase opportunities to adopt healthybehaviours."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Educate patients and caregivers on safe, effective and appropriate medication use, health and wellness, medication administration, self-care, home health-care equipment and health-monitoring devices","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","SC4.1 Provide effective education to others.","SC4.2 Employ appropriate teaching roles when teaching others.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM2.2 Allocate health care resources for optimal patient care."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Assume the role of the pharmacist in each of the lab activities and take responsibility and accountability","PR1 Committed to apply best practicesand adhere to high ethicalstandards in the delivery ofpharmacy care.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Differentiate the scope of practice of pharmacists and pharmacy technicians","CL1.1 Establish and maintain positive relationships.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate the principles of evidence based clinical practice to solve drug therapy and health-related issues","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,Display a professional attitude as outlined in professionalism expectations,"PR1 Committed to apply best practicesand adhere to high ethicalstandards in the delivery ofpharmacy care.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","PR2 Able to recognize and respond tosocietal expectations of regulatedhealth care professionals.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals.","PR3 Committed to self-awareness inthe management of personal andprofessional well being.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements.","PR3.2 Examine, reflect upon and manage personal attributes (knowledge, skills,beliefs, biases, motivations, emotions) that could influence self-development and professional performance.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Describe the principles of shared decision making (SDM) ","CL1.3 Join with others in respectful, effective shared decision-making."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Locate and apply appropriate tertiary literature in response to a clinical question","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Explain the purpose and place of patient decision aids"
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Understand language that is appropriate for explaining risk/benefit to patients","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Identify and report an adverse drug reaction","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Describe the differences in case presentation formats","CL2 Hand over the care of a patient toother pharmacy team membersand non-pharmacy team membersto facilitate continuity of safepatient care.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate the mastery of a skill by teaching another HCP how to properly use and counsel of respiratory devices; and prepare an outline for teaching physiotherapy students"
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate effective written communication skills when communicating with patients, caregivers and other HCP; documenting patient care activities; and when responding to drug information questions. ","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CM1 Communicate in a responsible andresponsive manner that encouragestrust and confidence.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CM2 Communicate in a manner that supports a team approach to health promotion and health care.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM2.2 Allocate health care resources for optimal patient care.","SC4.1 Provide effective education to others.","SC4.2 Employ appropriate teaching roles when teaching others.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers.","PR2.1 Take responsibility and accountability for actions and inactions."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate effective written communication when using a DAP note or care plan; in preparing a patient decision-aid; and in preparing a discharge prescription"
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate effective verbal communication skills when: conducting patient interviews, interacting with pharmacy colleagues and other HCP, communicating recommendations and rationale to patients and other HCP","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CM1 Communicate in a responsible andresponsive manner that encouragestrust and confidence.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM2.2 Allocate health care resources for optimal patient care.","SC4.1 Provide effective education to others.","SC4.2 Employ appropriate teaching roles when teaching others.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate effective verbal communication skills when: presenting a case to other health-care professionals; presenting an article using journal club format; engaging in shared decision making discussion; and, engaging in risk/benefit discussions of therapeutic alternatives"
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Complete a medication reconciliation for ensuring continuity of patient care during admission, discharge and transition between facilities","CM1.7 Compose and share oral, written and electronic information in a mannerthat optimizes patient safety, dignity, confidentiality and privacy.","CP3 Actively contribute, as anindividual and as a member of ateam providing care, to thecontinuous improvement of healthcare quality and patient safety.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","CL2.1 Determine when and how care should be handed over to another teammember.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Apply the standards of practice, laws and regulations governing pharmacy practice in community pharmacy including: interpreting and processing prescription orders, assessing prescriptions for appropriateness, integrating the drug use process and the patient care process (reviewing, processing and checking prescriptions), applying basic pharmaceutical math to the drug use process, and discussing ethical issues and professionalism"
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35," "
"PHARM 330A (Fall 2017 LAB D1 D2 LEC C1)","PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year",3,"Renette Bertholet, Theresa Charrois, Gillian Johnson",,6,35,"Demonstrate an understanding of the standards of practice regarding: (a) acting professionally (standards 1 and 2); (b) considering appropriate information (standard 3); (c) determining the appropriateness of a prescription (standard 6); (d) adaptation of prescriptions (standards 11 and 12); (e) dispensing a prescription (standard 7); and (f) documentation (standard 18)","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.2 Formulate assessments of actual and potential issues and in collaboration with the patient and other health team members as appropriate, prioritize issues to be addressed in a given patient encounter."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Develop a caring, empathic attitude for patients experiencing the conditions covered.","PR1.1 Exhibit professional behaviour whether face-to-face, in writing or viatechnology-enabled communication. Professional behaviour includes but isnot limited to:a) demonstrating honesty, integrity, humility, commitment, altruism,compassion, respect and respect for diversity and patient autonomy;b) being accessible, diligent, timely and reliable in service to others;c) abiding by the principle of non-abandonment;d) maintaining appropriate interpersonal boundaries;e) maintaining professional composure, demeanour and language even indifficult situations; andf) maintaining privacy and confidentiality.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Identify and locate sources of information needed to provide patient care.","LM2.2 Allocate health care resources for optimal patient care.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","HA2.1 Work with a community or population to identify the determinants ofhealth that affect them.","HA2.2 Participate in health promotion and disease prevention programs."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Develop an appreciation of the interdisciplinary nature of patient care.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CL1.3 Join with others in respectful, effective shared decision-making.","CL2.2 Recognize, respect and honour the negotiated shared and overlappingresponsibilities of patients, pharmacy team members and other health teammembers when handovers occur.","CL2.3 Demonstrate safe handover of care, using oral, written and electroniccommunication, during a patient transition to a different care provider orsetting."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","HA2.2 Participate in health promotion and disease prevention programs.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.3 Create and document plans in collaboration with the patient and other health team members as appropriate, and make recommendations to prevent, improve or resolve issues.","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Outline the economic and health policy issues as they relate to mental health conditions.","HA2.2 Participate in health promotion and disease prevention programs.","PR1.4 Engage in activities that:a) protect the public; andb) advance the practice of pharmacy."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Identify ethical issues in the management of mental health conditions.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Evaluate and apply information from literature and other resources to provide patient care.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry."
"PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2)","PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Pharmacy Practice,, BSc in Pharmacy, 3rd year",2,"Candace Necyk",,3,24,"Utilize independent and collaborative approaches to learning.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","CL1.3 Join with others in respectful, effective shared decision-making."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Explain the anatomy of blood supply and the lymphatic system of the human.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Explain the effects of drugs used in the management of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)","SC3.1 Apply scientific principles of research and scholarly inquiry.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Identify ethical issues surrounding treatment of the conditions of primary focus."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Identify applicable health system resources","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Accept responsibility for keeping abreast of emerging technologies and drugs","PR2.1 Take responsibility and accountability for actions and inactions."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CL2.1 Determine when and how care should be handed over to another teammember."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring","CP1.1 Apply knowledge from the foundational sciences to make decisions relevant to the contemporary and evolving scope of pharmacist practice."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Utilize an evidence based approach to therapeutic management of the conditions of primary focus.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Identify and locate sources of information needed to solve drug related problems","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Critically evaluate the appropriateness and reliability of information from literature resources","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 347 (Fall 2017 LEC A1 SEM E1)","PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17",2017,Fall,"Cross Listed Courses","Therapeutics,, BSc in Pharmacy, 2nd year",1,"Dr. Paul Jurasz",,3,15,"Utilize self-directed learning abilities","SC2.4 Incorporate best available evidence in the decision-making process."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Clarify roles, responsibilities and expertise of team members, identifying overlaps and gaps.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Apply regulatory and profession best practices to manage the distribution of medications in a variety of practice settings.","CP1 Practise within the pharmacist scope of practice and expertise.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Evaluate factors critical to safe and efficient medication distribution systems including pharmacy layout, workflow, technology and automation.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","PR2.2 Demonstrate a commitment to patient safety and quality improvement."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Evaluate the quality of care and the cost effectiveness of services they provide.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","PR2.2 Demonstrate a commitment to patient safety and quality improvement."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Disclose, manage and report errors, incidents and unsafe practices.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","PR2.2 Demonstrate a commitment to patient safety and quality improvement."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Ensure that pharmacy technicians and staff are delegated and undertake functions appropriate to their training and legislation.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:"
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Apply best practices in staff selection, training, development and evaluation.","LM2.3 Contribute to the management of finances and health human resources inpharmacy practice settings."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Critique the impact of funding and payment policies on the provision of professional services.","LM2.2 Allocate health care resources for optimal patient care."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Describe strategic planning principles."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Describe marketing principles in the context of supply and demand for professional services."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Utilize inventory control concepts to maintain an inventory control system."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Create a business plan for the provision of professional services."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Help maintain a healthy work environment and assist with conflict management.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Make their points of view known, listen to and respect the opinions of others, defend points of view if necessary.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Contribute to planning, organizing and performing of work to be done, and integrating evidence while evaluating the results.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","LM1.1 Work with others to apply quality improvement strategies and techniquesto optimize pharmacy care.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety.","LM2.1 Apply evidence and management processes to achieve cost appropriatecare.","LM2.2 Allocate health care resources for optimal patient care."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Support continued efforts of the group by providing positive feedback, including evidence of progress and impact.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Set priorities and manage their time to balance patient care, workflow and practice requirements.","LM4.2 Use effective strategies to manage and improve their own practice ofpharmacy.","PR3.1 Set professional and personal goals, priorities and manage their time tobalance patient care, workflow and practice requirements."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Adapt their practice to fulfill evolving professional roles.","PR3.3 Adapt their practice of pharmacy to fulfill evolving professional roles.","PR2.5 Demonstrate an ability to maintain competence to practise throughevaluating areas for improvement and planning, undertaking learningactivities to address limitations in competence and/or performance andincorporating learning into practice."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Anticipate, recognize and manage human, environmental and medication distribution situations that place patients at risk.","CP3.1 Recognize and respond to harm and potential harm from health care delivery, including patient safety incidents.","CP3.2 Adopt strategies that promote patient safety and address human and system factors.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals.","PR3.4 Recognize and respond to self and colleagues in need."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Supervise members of the pharmacy team, including pharmacy technicians, to ensure competent performance of functions.","LM4.1 Work with others to apply the principles of effective management andsupervision of health human resources and medication use systems.","CL1.2 Recognize, respect and negotiate the roles and shared/overlappingresponsibilities of team members."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Develop a willingness to accept leadership roles where appropriate.","LM3.1 Demonstrate leadership skills to enhance pharmacy practice and healthcare."
"PHARM 372 (LEC A1 Fa17)","PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",2,"Jody Shkrobot",,17,14,"Develop a willingness to respect the rules established by the group.","CM2.4 In word and in action, convey the importance of teamwork in patient-centred care, patient safety, health care quality improvement and healthprogram delivery.","CL1 Work effectively with members ofthe health team including patients,pharmacy colleagues andindividuals from other professions."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Describe the types of information found in some common pharmacy tertiary and secondary reference sources.","SC2.1 Generate focused questions related to needs for information, recommendationsand decisions in practice.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Identify the functions and services offered by the health sciences library.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Use library resources and library facilities effectively to access relevant drug information. ","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","LM1.3 Confirm the quality, safety and integrity of products.","LM1.4 Use health informatics to improve the quality of care, manage resourcesand optimize patient safety."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Obtain relevant background information from the client about the patient, disease, and/or drug.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CL1.1 Establish and maintain positive relationships.","HA1.1 Work with patients to address determinants of health that affect them andtheir access to needed health services or resources.","SC1.1 Use knowledge and problem-solving to arrive at recommendations and decisionsthat are appropriate, accurate and practical.","SC1.2 Use professional experience to solve routine, previously encountered problems.","SC1.3 Use established decision-making frameworks and apply learning required tomanage new situations and problems.","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Demonstrate a systematic step-wise approach to answer drug information requests.","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CP1.4 Explain the benefits, risks and rationale associated with pharmacist-provided care as an important step in obtaining and documenting consentto pharmacist care.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered.","CP2.1 Collect, interpret and assess relevant, necessary information about a patients health-related care needs.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ","SC2.2 Use systematic approaches in the search for best available evidence.","SC2.3 Critically appraise health-related research and literature.","SC2.4 Incorporate best available evidence in the decision-making process.","SC3.1 Apply scientific principles of research and scholarly inquiry."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Determine the depth of response required for any given question. ","CP1.3 Recognize and respond to the complexity, uncertainty and ambiguity inherent in pharmacy practice.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.6 Seek and synthesize relevant information from others in a manner that ensures common understanding and where applicable, clarifies and secures agreement and/or consent.","CL1.3 Join with others in respectful, effective shared decision-making.","LM1.2 Contribute to a culture of patient safety.","LM2.2 Allocate health care resources for optimal patient care.","SC4.1 Provide effective education to others.","SC4.4 Use appropriate learning assessment and evaluation strategies when workingwith patients, team members, students and teachers."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.","CM1.4 Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.","CM1.1 Select and use oral, non-verbal and written communication strategies (tools, techniques, technologies) effectively so that the patients best interests are foremost.","CM1.2 Provide timely, clear responses that are tailored to the context andaudience.","CM1.3 Express facts, evidence, opinions and positions accurately and effectively, with clarity and confidence.","CM1.5 Use language, pace, tone and non-verbal communication that is suitable for:a) the intended outcomes of the communication, andb) the complexity, ambiguity, urgency and/or difficulty of a situation,conversation or conflict.","CM2.1 Engage in respectful, empathetic, compassionate, non-judgmental,culturally safe, tactful conversations with patients, communities,populations and health team members.","CM2.2 Demonstrate awareness of the impact of ones own experience level,professional culture, biases and power and hierarchy within the health teamon effective working relationships, communication and conflict resolutionwith health team members and adapt the approach to the situationappropriately.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Follow-up on drug information requests where appropriate.","CP2.4 Implement plans in collaboration with the patient and other health team members as appropriate, including:","CP2.5 Follow-up by monitoring, evaluating progress toward achievement of the patients goals of therapy, adjusting plans in collaboration with the patient and health team members across the care continuum."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Apply legal and ethical principles to issues that may occur in practice.","CM2.3 Demonstrate accuracy and appropriateness of communication as well asrespect for the role of other health team members when disclosinginformation about harmful or potentially harmful situations.","SC3.2 Apply ethical principles that underlie research and scholarly inquiry.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR1.3 Recognize and respond to situations presenting ethical dilemmas, includingconflicts of interest.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.3 Honour the laws, ethical codes and regulatory requirements (by-laws,standards, policies) that govern the self-regulated profession of pharmacy.","PR2.6 Identify and respond to unprofessional, unethical and illegal behaviours inpharmacists, other pharmacy team members and other healthprofessionals."
"PHARM 304 (LEC A2 Fa17)","PHARM 304 - DRUG INFORMATION (Fall 2017)",2017,Fall,"Faculty of Pharmacy and Pharmaceutical Sciences","BSc in Pharmacy",0.5,"Ken Cor",,4,18,"Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.","PR1.2 Use ethical frameworks as one component of professional judgment.","PR2.1 Take responsibility and accountability for actions and inactions.","PR2.2 Demonstrate a commitment to patient safety and quality improvement.","LM1.2 Contribute to a culture of patient safety.","CP1.5 Recognize and take appropriate action when signs, symptoms and risk factors that relate to medical or health problems that fall into the scope of practice of other health professionals are encountered."
